Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
HTFL
$22.77
$
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
Next Earnings
2026-02-25
Beta
6.042822
Average Volume
Market Cap
Last Dividend
CIK
0001464521
ISIN
US42238D1072
CUSIP
42238D107
CEO
John Farquhar
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full Time Employees
626
IPO Date
2025-08-07
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference | MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET. | GlobeNewsWire | 2026-02-18 16:05:00 |
| 2025 U.S. IPO Performance Starts With A Roar And Ends With A Whimper | 2025 US IPOs emerged out of a tumultuous April with strong price momentum going into the summer. US IPOs under $100 million in proceeds continued to perform poorly in 2025 after also struggling in 2024, with the less than $50 million issues declining 18.4% this year compared to a 17.1% decline last year. The strong performance of US technology IPOs during the first half of 2025 set the stage nicely for more issuers to go public during the second half of the year. | Seeking Alpha | 2026-02-15 07:46:00 |
| Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 | MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Wednesday, March 18, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on March 18, 2026. | GlobeNewsWire | 2026-02-13 16:21:00 |
| Insider Selling: Heartflow (NASDAQ:HTFL) Director Sells $218,560.00 in Stock | Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) Director Julie Cullivan sold 8,000 shares of Heartflow stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $27.32, for a total value of $218,560.00. Following the completion of the transaction, the director owned 36,413 shares of the company's stock, valued | Defense World | 2026-02-12 05:42:53 |
| Heartflow (NASDAQ:HTFL) Sets New 1-Year Low After Insider Selling | Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) reached a new 52-week low during trading on Wednesday after an insider sold shares in the company. The stock traded as low as $25.36 and last traded at $26.42, with a volume of 575570 shares trading hands. The stock had previously closed at $27.30. Specifically, CEO John C.M. | Defense World | 2026-02-12 02:38:29 |
| Baron Opportunity Fund Q4 2025 Portfolio Activity | We invest in secular growth and innovative businesses across all market capitalizations, with the bulk of the portfolio landing in the large-cap zone. We recently initiated a position in Axon Enterprise. We exited our successful investment in Exact Sciences Corporation after Abbott Laboratories announced it was acquiring the company for approximately $23 billion in cash. | Seeking Alpha | 2026-02-12 01:20:00 |
| Market Today: Dow tops 50,000 as chip leaders rebound; Stellantis plunges | Guru Stock PicksTom Gayner has made the following transactions:Reduce in ADI by 12.37%Sold out in ADBEAdd in TMO by 12.54%New position in BRORichard Pzena has m | GuruFocus | 2026-02-06 17:35:00 |
| Heartflow, Inc.’s Lock-Up Period Will Expire on February 4th (NASDAQ:HTFL) | Heartflow's (NASDAQ: HTFL - Get Free Report) lock-up period is set to end on Wednesday, February 4th. Heartflow had issued 16,666,667 shares in its public offering on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. After the end of Heartflow's lock-up period, restrictions preventing major shareholders | Defense World | 2026-01-28 01:12:53 |
| Baillie Gifford & Co. Takes $101.18 Million Position in Heartflow, Inc. $HTFL | Baillie Gifford and Co. bought a new position in Heartflow, Inc. (NASDAQ: HTFL) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 3,005,998 shares of the company's stock, valued at approximately $101,182,000. Baillie Gifford and Co. owned 3.60% of Heartflow as of its most recent filing | Defense World | 2026-01-25 03:28:45 |
| HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript | HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript | Seeking Alpha | 2026-01-13 19:06:00 |
| Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. | MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. | GlobeNewsWire | 2026-01-06 08:00:00 |
| Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference | MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 13, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. | GlobeNewsWire | 2026-01-05 16:05:00 |
| Is Recent IPO Stock Heartflow a Buy After a Director Scooped Up Shares Worth Over $1 Million? | Jeffrey Lightcap, a member of the Board of Directors of HeartFlow (HTFL 2.00%), acquired 40,000 common shares in an open-market transaction valued at $1,053,680 on Dec. 16, 2025; see SEC Form 4 filing. | The Motley Fool | 2025-12-28 01:08:38 |
| Why AI Stock HeartFlow Triumphed on Thursday | The specialized healthcare diagnostics company earned two endorsements from heart health organizations. These concerned HeartFlow's plaque detection product. | The Motley Fool | 2025-12-18 19:22:39 |
| Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD | Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment | GlobeNewsWire | 2025-12-18 16:05:00 |
| Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health Service Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health Service | GlobeNewsWire | 2025-12-11 03:10:00 |
| Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO | Tulsa-based Schusterman Interests added 1,939,201 shares of HeartFlow valued at $65.3 million in the third quarter. The position represents 14.9% of the fund's 13F reportable assets under management. | The Motley Fool | 2025-11-30 17:49:42 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 4 | 2026-02-19 | 2026-02-19 | View Filing |
| 4 | 2026-02-17 | 2026-02-17 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| SC 13G/A | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-06 | 2026-02-06 | View Filing |
| 4 | 2026-02-06 | 2026-02-06 | View Filing |
| 8-K | 2026-01-12 | 2026-01-12 | View Filing |
| 4 | 2025-12-17 | 2025-12-17 | View Filing |
| SC 13G | 2025-11-24 | 2025-11-24 | View Filing |
| SC 13G | 2025-11-14 | 2025-11-14 | View Filing |
| SC 13G | 2025-11-14 | 2025-11-14 | View Filing |
| 4 | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-11-12 | 2025-11-12 | View Filing |
| 10-Q | 2025-11-12 | 2025-11-12 | View Filing |
| 8-K | 2025-11-12 | 2025-11-12 | View Filing |
| SC 13G | 2025-11-12 | 2025-11-12 | View Filing |
| SC 13G | 2025-11-05 | 2025-11-05 | View Filing |
| 10-Q | 2025-09-19 | 2025-09-19 | View Filing |
| 8-K | 2025-09-10 | 2025-09-10 | View Filing |
| 8-K | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-22 | 2025-08-22 | View Filing |
| 3 | 2025-08-22 | 2025-08-22 | View Filing |
| 4 | 2025-08-13 | 2025-08-13 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| S-8 | 2025-08-11 | 2025-08-11 | View Filing |
| S-8 | 2025-08-11 | 2025-08-11 | View Filing |
| 8-K | 2025-08-11 | 2025-08-11 | View Filing |
| 424B4 | 2025-08-08 | 2025-08-08 | View Filing |
| EFFECT | 2025-08-08 | 2025-08-08 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| 3 | 2025-08-07 | 2025-08-07 | View Filing |
| CERT | 2025-08-07 | 2025-08-07 | View Filing |
| 8-A12B | 2025-08-07 | 2025-08-07 | View Filing |
| S-1/A | 2025-08-06 | 2025-08-06 | View Filing |
| S-1/A | 2025-08-01 | 2025-08-01 | View Filing |
| S-1 | 2025-07-17 | 2025-07-17 | View Filing |
| DRS/A | 2025-06-23 | 2025-06-21 | View Filing |
| DRS/A | 2025-04-18 | 2025-04-18 | View Filing |
| DRS/A | 2025-03-27 | 2025-03-27 | View Filing |
| DRS | 2025-02-06 | 2025-02-06 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|